BRPI0502736A - formulações orais de ondansetrona com sabor residual mascarado - Google Patents

formulações orais de ondansetrona com sabor residual mascarado

Info

Publication number
BRPI0502736A
BRPI0502736A BRPI0502736-5A BRPI0502736A BRPI0502736A BR PI0502736 A BRPI0502736 A BR PI0502736A BR PI0502736 A BRPI0502736 A BR PI0502736A BR PI0502736 A BRPI0502736 A BR PI0502736A
Authority
BR
Brazil
Prior art keywords
ondansetron
oral formulations
residual flavor
masked
masked residual
Prior art date
Application number
BRPI0502736-5A
Other languages
English (en)
Inventor
Dante Junior Alario
Original Assignee
Biolab Sanus Farmaceutica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37604052&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0502736(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biolab Sanus Farmaceutica Ltda filed Critical Biolab Sanus Farmaceutica Ltda
Priority to BRPI0502736-5A priority Critical patent/BRPI0502736A/pt
Priority to PCT/BR2006/000015 priority patent/WO2007003020A1/en
Publication of BRPI0502736A publication Critical patent/BRPI0502736A/pt
Priority to EC2008008079A priority patent/ECSP088079A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)

Abstract

"FORMULAçõES ORAIS DE ONDANSETRONA COM SABOR RESIDUAL MASCARADO". Composições farmacêuticas para uso oral caracterizadas por conterem sais solúveis de ondansetrona e edulcorantes com alto poder adoçante em elevadas proporções em relação ao ingrediente ativo.
BRPI0502736-5A 2005-07-05 2005-07-05 formulações orais de ondansetrona com sabor residual mascarado BRPI0502736A (pt)

Priority Applications (3)

Application Number Priority Date Filing Date Title
BRPI0502736-5A BRPI0502736A (pt) 2005-07-05 2005-07-05 formulações orais de ondansetrona com sabor residual mascarado
PCT/BR2006/000015 WO2007003020A1 (en) 2005-07-05 2006-02-06 Oral formulations comprising ondansetron and a highly dosed sweeten
EC2008008079A ECSP088079A (es) 2005-07-05 2008-01-04 Formulaciones orales que comprenden ondansetrón y un edulcorante altamente dosificado

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0502736-5A BRPI0502736A (pt) 2005-07-05 2005-07-05 formulações orais de ondansetrona com sabor residual mascarado

Publications (1)

Publication Number Publication Date
BRPI0502736A true BRPI0502736A (pt) 2007-02-27

Family

ID=37604052

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0502736-5A BRPI0502736A (pt) 2005-07-05 2005-07-05 formulações orais de ondansetrona com sabor residual mascarado

Country Status (3)

Country Link
BR (1) BRPI0502736A (pt)
EC (1) ECSP088079A (pt)
WO (1) WO2007003020A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1401086B1 (it) * 2010-07-19 2013-07-12 Farmalip S R L Dolcificante.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10109763A1 (de) * 2001-02-28 2002-09-05 Gruenenthal Gmbh Pharmazeutische Salze
AU2002255196A1 (en) * 2002-04-18 2003-10-27 Dr. Reddy's Laboratories Ltd. Rapidly dispersing solid oral compositions

Also Published As

Publication number Publication date
WO2007003020A1 (en) 2007-01-11
ECSP088079A (es) 2008-02-20

Similar Documents

Publication Publication Date Title
TW200728285A (en) Diacylindazole derivatives as inhibitors of lipases and phospholipases
TW200800987A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
NO20084256L (no) DPP IV inhibitorformuleringer
NO20063430L (no) Generelt lineaer, brusende oral fentanyl doseringsform, og metoder for administrering
TW200730513A (en) Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
GT200600520A (es) Agentes antibacterianos
TW200722421A (en) Azole derivatives as inhibitors of lipases and phospholipases
UY32203A (es) Amino pirimidinas y su uso en terapia
MX2007004736A (es) Composicion farmaceutica que comprende diclofenaco.
BRPI0407306A (pt) 1,2,4- triazinas de inibição de hiv
TNSN08061A1 (en) Liquid formulations
ECSP077238A (es) Composiciones para entrega de drogas altamente solubles en agua
ECSP109852A (es) Uso de homo y copolímeros para la estabilización de formulaciones de principios activos
WO2006136580A3 (en) 2-(phenylamino)benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
SG152257A1 (en) Topical preparation containing ambroxol
NO20075111L (no) Farmasoytisk sammensetning
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
IL186050A0 (en) Novel isoindole derivatives, compositions containing same, preparation thereof and pharmaceutical uses thereof in particular as inhibitors of chaperone protein hsp90 activities
BRPI0508596A (pt) combinação compreendendo ligante alfa-2-delta
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
ZA200804163B (en) New adjuvants on the basis of bisacyloxypropylcysteine conjugates and derivatives and their uses in pharmaceutical compositions
ITMI20020189A1 (it) Composizione per uso farmaceutico o dietetico per contrastare la caduta dei capelli
CL2009001267A1 (es) Compuestos derivados de triciclos nitrogenados, con actividad antibacteriana; procedimiento de preparacion; composicion farmceutica que los comprende; para el tratamiento de la tuberculosis.
MX2007010930A (es) Formulacion de aviptadil.

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Ipc: A61K 9/10 (2010.01), A61K 31/41 (2010.01), A61K 9/

B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07D Technical examination (opinion) related to article 229 of industrial property law
B07E Notice of approval relating to section 229 industrial property law
B07A Technical examination (opinion): publication of technical examination (opinion)
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/41 (2006.01), A61K 9/10 (2006.01), A61K 9/

B09B Decision: refusal
B12B Appeal: appeal against refusal